SAN DIEGO, Feb. 25 /PRNewswire-FirstCall/ -- Bio-Matrix Scientific Group, Inc. (OTC Bulletin Board: BMSN) announced today that it has added two members to newly created positions on its management team. Feng Lin, M.D., Ph.D. has joined the biotech research and development company as Laboratory/Scientific Director and Marilyn Panahi is serving as Quality Assurance Director.
"Dr. Feng Lin and Marilyn Panahi bring tremendous expertise to the administrative operations of BMSN's laboratories to ensure all of the varied facets meet government regulations and compliance," said David Koos, Chairman and CEO, BMSN.
As Laboratory/Scientific Director, Dr. Lin is responsible for the overall operation, leadership, direction, and administration of BMSN's Laboratory in accordance with Federal and State Regulations governing laboratories.
As Quality Assurance Director, Ms. Panahi is responsible for managing and assuring regulatory compliance requirements including validation, customer complaints, and review of product manufacture records, audits, and quality assurance documentation. .
Dr. Feng Lin has a strong background in drug/DNA in vivo delivery,
oncology and tumor immunotherapy, DNA vaccination, cell and molecular biology,
and animal model work. He also has extensive experience with tissue imaging,
DNA vaccine design, antibody- and cell-based assay. Previously, Dr. Lin was a
Senior Research Scientist, Research & Development with Inovio Biomedical
Corp., San Diego. He received his M.D. from Central
Marilyn Panahi brings more than 15 years experience in the implementation
and management of th
|SOURCE Bio-Matrix Scientific Group, Inc.|
Copyright©2009 PR Newswire.
All rights reserved